Mutations within the tumour suppressor gene p53 are not confined to a late event in prostate cancer progression
- 1 May 2001
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 6 (3) , 103-110
- https://doi.org/10.1016/s1078-1439(00)00119-8
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Differences in the p53 gene mutational spectra of prostate cancers between Japan and Western countriesCarcinogenesis: Integrative Cancer Research, 1997
- p53 Abnormalities in Primary Prostate Cancer: Single-Strand Conformation Polymorphism Analysis of Complementary DNA in Comparison With Genomic DNAJNCI Journal of the National Cancer Institute, 1997
- The role of the p53 tumor suppressor gene in prostate cancer: A possible biomarker?Urology, 1996
- Molecular biology of prostatic intraepithelial neoplasiaThe Prostate, 1996
- Frequency and characterization of p53 mutations in clinically localized prostate cancerUrology, 1995
- Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cellsThe Prostate, 1994
- p53 in Prostate Cancer: Frequent Expressed Transition MutationsJNCI Journal of the National Cancer Institute, 1994
- Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancerBritish Journal of Cancer, 1993
- p53 and c-myc Expression in Stage A1 Prostatic Adenocarcinoma: Useful Prognostic Determinants?Journal of Urology, 1993
- Mutant p53 expression in prostate carcinomaThe Prostate, 1993